Exenatide and acute pancreatitis.
For a female, type 2 diabetic patient, with 4 years duration of diabetes, Exenatide (Byetta) was prescribed as glycaemic control was not satisfactory along with Glimepiride and Metformin. She had gastrointestinal disturbances, since the first day of the injection. From the eighth day she developed signs of acute pancreatitis which was confirmed with CT-Scan and biochemical investigations. Byetta was withdrawn, the patient was treated for acute pancreatitis and the symptoms subsided.
Tripathy
N R
NR
Dr. A. Ramachandran's Diabetes Hospitals, Chennai 600 008, India.
Basha
S
S
Jain
R
R
Shetty
S
S
Ramachandran
A
A